01546nam a2200265 a 450000100080000000500110000800800410001902400550006010000250011524501840014026001990032452004950052365000200101870000190103870000150105770000220107270000170109470000260111170000200113770000290115770000220118670000200120870000230122870000290125121539092023-12-14       2023    bl uuuu     u00u1 u    #d7 ahttps://doi.org/10.1093/ecco-jcc/jjac190.01462DOI1 aNASCIMENTO, R. P. DO  aDietary supplementation with Brazilian jaboticaba-sabará fruit (Myrciaria jaboticaba (Vell.) O. Berg) ameliorates colitis-driven colorectal cancer in mice.h[electronic resource]  aJournal of Crohn's and Colitis, v. 17, suppl. 1, 2023, p. i186-i188. Edicão dos abstracts do XVIII CONGRESS OF EUROPEAN CROHN'S AND COLITIS ORGANISATION ECCO, Copenhagen, 2023. Ref. P016.c2023  aIndividuals with inflammatory bowel diseases (IBD) are at a high risk of developing colorectal cancer (CRC). Recently, pre-clinical studies have demonstrated that South American crops are rich sources of bioactive compounds that can act against both IBD and CRC. Therefore, our study aimed to characterize the freeze-dried peel of jaboticaba-sabará (Myrciaria jaboticaba (Vell.) O. Berg), a native Brazilian berry, and understand its preventive effects on a mouse model of IBD-related CRC.  aFood technology1 aRIZZATO, J. S.1 aPOLEZI, G.1 aMOYA, A. M. T. M.1 aSILVA, M. F.1 aFRANCHI JUNIOR, G. C.1 aBORGUINI, R. G.1 aSANTIAGO, M. C. P. de A.1 aPAIOTTI, A. P. R.1 aPERREIRA, J. A.1 aMARTINEZ, C. A. R.1 aMARÓSTICA JUNIOR, M. R.